vs

Side-by-side financial comparison of Himalaya Shipping Ltd. (HSHP) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($37.2M vs $29.9M, roughly 1.2× Himalaya Shipping Ltd.). On growth, Himalaya Shipping Ltd. posted the faster year-over-year revenue change (-4.2% vs -57.1%).

Himalaya Shipping Ltd. is a global maritime transportation enterprise focused on dry bulk shipping operations. It operates a fleet of modern, fuel-efficient bulk carriers that transport key commodities including iron ore, coal, grain and other bulk raw materials, serving core trade routes across Asia, Europe, and the Americas to support global industrial and agricultural supply chain flows.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

HSHP vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.2× larger
ORGO
$37.2M
$29.9M
HSHP
Growing faster (revenue YoY)
HSHP
HSHP
+52.9% gap
HSHP
-4.2%
-57.1%
ORGO

Income Statement — Q2 FY2025 vs Q1 FY2026

Metric
HSHP
HSHP
ORGO
ORGO
Revenue
$29.9M
$37.2M
Net Profit
$1.1M
Gross Margin
76.3%
30.8%
Operating Margin
45.5%
-185.1%
Net Margin
3.7%
Revenue YoY
-4.2%
-57.1%
Net Profit YoY
-84.1%
EPS (diluted)
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HSHP
HSHP
ORGO
ORGO
Q1 26
$37.2M
Q4 25
$225.6M
Q3 25
$150.9M
Q2 25
$29.9M
$101.0M
Q1 25
$86.7M
Q4 24
$126.7M
Q3 24
$115.2M
Q2 24
$31.2M
$130.2M
Net Profit
HSHP
HSHP
ORGO
ORGO
Q1 26
Q4 25
$43.7M
Q3 25
$21.6M
Q2 25
$1.1M
$-9.4M
Q1 25
$-18.8M
Q4 24
$7.7M
Q3 24
$12.3M
Q2 24
$6.9M
$-17.0M
Gross Margin
HSHP
HSHP
ORGO
ORGO
Q1 26
30.8%
Q4 25
Q3 25
Q2 25
76.3%
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
82.1%
77.6%
Operating Margin
HSHP
HSHP
ORGO
ORGO
Q1 26
-185.1%
Q4 25
28.1%
Q3 25
13.7%
Q2 25
45.5%
-12.5%
Q1 25
-30.9%
Q4 24
8.1%
Q3 24
5.4%
Q2 24
56.1%
-10.7%
Net Margin
HSHP
HSHP
ORGO
ORGO
Q1 26
Q4 25
19.4%
Q3 25
14.3%
Q2 25
3.7%
-9.3%
Q1 25
-21.7%
Q4 24
6.1%
Q3 24
10.7%
Q2 24
22.1%
-13.1%
EPS (diluted)
HSHP
HSHP
ORGO
ORGO
Q1 26
Q4 25
$0.31
Q3 25
$0.11
Q2 25
$0.02
$-0.10
Q1 25
$-0.17
Q4 24
$0.05
Q3 24
$0.09
Q2 24
$0.16
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HSHP
HSHP
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$24.7M
$91.4M
Total DebtLower is stronger
$701.3M
Stockholders' EquityBook value
$159.3M
Total Assets
$871.9M
$520.0M
Debt / EquityLower = less leverage
4.40×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HSHP
HSHP
ORGO
ORGO
Q1 26
$91.4M
Q4 25
$93.7M
Q3 25
$63.7M
Q2 25
$24.7M
$73.1M
Q1 25
$110.0M
Q4 24
$135.6M
Q3 24
$94.3M
Q2 24
$21.9M
$89.9M
Total Debt
HSHP
HSHP
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
$701.3M
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$725.5M
$63.8M
Stockholders' Equity
HSHP
HSHP
ORGO
ORGO
Q1 26
Q4 25
$300.1M
Q3 25
$255.1M
Q2 25
$159.3M
$233.2M
Q1 25
$242.9M
Q4 24
$262.9M
Q3 24
$278.5M
Q2 24
$157.2M
$263.5M
Total Assets
HSHP
HSHP
ORGO
ORGO
Q1 26
$520.0M
Q4 25
$598.7M
Q3 25
$509.8M
Q2 25
$871.9M
$461.1M
Q1 25
$467.4M
Q4 24
$497.9M
Q3 24
$446.3M
Q2 24
$897.3M
$443.2M
Debt / Equity
HSHP
HSHP
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
4.40×
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
4.61×
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HSHP
HSHP
ORGO
ORGO
Operating Cash FlowLast quarter
$8.3M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
7.55×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HSHP
HSHP
ORGO
ORGO
Q1 26
Q4 25
$39.4M
Q3 25
$3.1M
Q2 25
$8.3M
$-32.9M
Q1 25
$-19.9M
Q4 24
$10.9M
Q3 24
$8.7M
Q2 24
$17.6M
$4.7M
Free Cash Flow
HSHP
HSHP
ORGO
ORGO
Q1 26
Q4 25
$34.8M
Q3 25
$844.0K
Q2 25
$-36.5M
Q1 25
$-23.6M
Q4 24
$7.6M
Q3 24
$6.1M
Q2 24
$2.9M
FCF Margin
HSHP
HSHP
ORGO
ORGO
Q1 26
Q4 25
15.4%
Q3 25
0.6%
Q2 25
-36.1%
Q1 25
-27.2%
Q4 24
6.0%
Q3 24
5.3%
Q2 24
2.2%
Capex Intensity
HSHP
HSHP
ORGO
ORGO
Q1 26
Q4 25
2.1%
Q3 25
1.5%
Q2 25
3.6%
Q1 25
4.2%
Q4 24
2.7%
Q3 24
2.2%
Q2 24
1.4%
Cash Conversion
HSHP
HSHP
ORGO
ORGO
Q1 26
Q4 25
0.90×
Q3 25
0.14×
Q2 25
7.55×
Q1 25
Q4 24
1.43×
Q3 24
0.71×
Q2 24
2.55×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons